Kovack Advisors Inc. Sells 390 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kovack Advisors Inc. cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 28.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 967 shares of the medical equipment provider’s stock after selling 390 shares during the period. Kovack Advisors Inc.’s holdings in Intuitive Surgical were worth $257,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Douglass Winthrop Advisors LLC lifted its stake in Intuitive Surgical by 2.0% during the first quarter. Douglass Winthrop Advisors LLC now owns 2,308 shares of the medical equipment provider’s stock worth $696,000 after purchasing an additional 46 shares during the last quarter. Evergreen Capital Management LLC lifted its stake in Intuitive Surgical by 2.2% during the first quarter. Evergreen Capital Management LLC now owns 2,279 shares of the medical equipment provider’s stock worth $688,000 after purchasing an additional 48 shares during the last quarter. Gerber Kawasaki Wealth & Investment Management lifted its stake in Intuitive Surgical by 4.3% during the third quarter. Gerber Kawasaki Wealth & Investment Management now owns 1,192 shares of the medical equipment provider’s stock worth $223,000 after purchasing an additional 49 shares during the last quarter. Pine Haven Investment Counsel Inc increased its holdings in shares of Intuitive Surgical by 2.9% during the fourth quarter. Pine Haven Investment Counsel Inc now owns 1,750 shares of the medical equipment provider’s stock worth $464,000 after buying an additional 50 shares in the last quarter. Finally, Bank of The West increased its holdings in shares of Intuitive Surgical by 1.0% during the fourth quarter. Bank of The West now owns 5,172 shares of the medical equipment provider’s stock worth $1,372,000 after buying an additional 51 shares in the last quarter. 81.96% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on ISRG shares. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $285.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, April 19th. Evercore ISI upped their price target on shares of Intuitive Surgical from $240.00 to $270.00 and gave the stock an “inline” rating in a report on Wednesday, April 19th. William Blair started coverage on shares of Intuitive Surgical in a report on Thursday, March 23rd. They set an “outperform” rating for the company. Mizuho upped their price target on shares of Intuitive Surgical from $240.00 to $250.00 and gave the stock a “neutral” rating in a report on Tuesday, April 18th. Finally, Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $289.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, April 19th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $303.35.

Intuitive Surgical Trading Up 0.3 %

ISRG stock opened at $329.36 on Friday. The stock has a 50-day moving average price of $301.35 and a 200-day moving average price of $269.53. Intuitive Surgical, Inc. has a 1-year low of $180.07 and a 1-year high of $333.14. The firm has a market cap of $115.41 billion, a PE ratio of 89.99, a price-to-earnings-growth ratio of 5.78 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last posted its quarterly earnings data on Tuesday, April 18th. The medical equipment provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.03. Intuitive Surgical had a return on equity of 11.39% and a net margin of 20.40%. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company posted $1.00 EPS. The business’s quarterly revenue was up 14.3% on a year-over-year basis. On average, analysts forecast that Intuitive Surgical, Inc. will post 4.3 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 9,623 shares of the business’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $299.76, for a total value of $2,884,590.48. Following the completion of the sale, the executive vice president now directly owns 327 shares of the company’s stock, valued at approximately $98,021.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, VP Marshall Mohr sold 11,250 shares of the business’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $325.00, for a total value of $3,656,250.00. Following the completion of the sale, the vice president now directly owns 24,136 shares of the company’s stock, valued at approximately $7,844,200. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 9,623 shares of Intuitive Surgical stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $299.76, for a total value of $2,884,590.48. Following the transaction, the executive vice president now owns 327 shares of the company’s stock, valued at approximately $98,021.52. The disclosure for this sale can be found here. Insiders sold 75,283 shares of company stock valued at $22,923,158 in the last three months. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.

Featured Articles

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.